GB2020975B - Compositions containg cyanine compounds - Google Patents

Compositions containg cyanine compounds

Info

Publication number
GB2020975B
GB2020975B GB7917270A GB7917270A GB2020975B GB 2020975 B GB2020975 B GB 2020975B GB 7917270 A GB7917270 A GB 7917270A GB 7917270 A GB7917270 A GB 7917270A GB 2020975 B GB2020975 B GB 2020975B
Authority
GB
United Kingdom
Prior art keywords
cyanine compounds
compositions containg
containg
compositions
cyanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7917270A
Other versions
GB2020975A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5927478A external-priority patent/JPS54151133A/en
Priority claimed from JP10354978A external-priority patent/JPS5531024A/en
Priority claimed from JP14385878A external-priority patent/JPS5569513A/en
Priority claimed from JP854479A external-priority patent/JPS55100318A/en
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of GB2020975A publication Critical patent/GB2020975A/en
Application granted granted Critical
Publication of GB2020975B publication Critical patent/GB2020975B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB7917270A 1978-05-17 1979-05-17 Compositions containg cyanine compounds Expired GB2020975B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5927478A JPS54151133A (en) 1978-05-17 1978-05-17 Antitumorigenic agent
JP10354978A JPS5531024A (en) 1978-08-24 1978-08-24 Anti-tumor agent
JP14385878A JPS5569513A (en) 1978-11-20 1978-11-20 Anti-tumor agent
JP854479A JPS55100318A (en) 1979-01-26 1979-01-26 Antitumorigenic agent

Publications (2)

Publication Number Publication Date
GB2020975A GB2020975A (en) 1979-11-28
GB2020975B true GB2020975B (en) 1983-03-30

Family

ID=27454964

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7917270A Expired GB2020975B (en) 1978-05-17 1979-05-17 Compositions containg cyanine compounds

Country Status (3)

Country Link
DE (1) DE2919447A1 (en)
FR (1) FR2425857A1 (en)
GB (1) GB2020975B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464383A (en) * 1981-11-24 1984-08-07 Itaru Yamamoto Immunomodulator containing trithiazole pentamethine cyanine derivative
EP0198605A1 (en) * 1985-03-19 1986-10-22 Teijin Limited Prophylaxis of pharmacotherapy of liver disorders
AU1144688A (en) * 1987-03-17 1988-09-15 Dana-Farber Cancer Institute, Inc. A pharmaceutical composition comprising cyanine dye
JP2824917B2 (en) * 1989-08-30 1998-11-18 株式会社林原生物化学研究所 Antitumor agent
ZA926004B (en) * 1991-08-13 1993-03-02 Fuji Photo Film Co Ltd Composition and method for treating cancer.
JPH10506878A (en) * 1994-07-21 1998-07-07 富士写真フイルム株式会社 Water-soluble methine compound and pharmaceutical composition containing the compound for treating cancer
DE19706161A1 (en) * 1997-02-17 1998-08-20 Oswald Hartmut Prof Dr Med Use of cyanines, isocyanines and pseudoisocyanines as diuretics
DE19841985A1 (en) * 1998-09-03 2000-03-09 Schering Ag New heterocyclic alkanesulfonic and alkane carboxylic acid derivatives are VEGF receptor blockers useful in treatment of e.g. psoriasis, rheumatoid arthritis, stroke, tumors and endometriosis
US6190641B1 (en) * 2000-01-18 2001-02-20 Mallinckrodt Inc. Indocyanine dyes
US6761878B2 (en) * 2001-10-17 2004-07-13 Mallinckrodt, Inc. Pathological tissue detection and treatment employing targeted benzoindole optical agents
GB0603455D0 (en) * 2006-02-21 2006-04-05 Cancer Rec Tech Ltd Therapeutic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387658A1 (en) * 1977-03-25 1978-11-17 Ciba Geigy Ag PROCEDURE FOR FIGHTING MICROORGANISMS

Also Published As

Publication number Publication date
GB2020975A (en) 1979-11-28
DE2919447A1 (en) 1979-11-22
FR2425857A1 (en) 1979-12-14
FR2425857B1 (en) 1982-12-03

Similar Documents

Publication Publication Date Title
GB2044098B (en) Compositions comprising 1,3-dimethyl-5-aminoadamantane
JPS54155292A (en) Photoopolymerizable composition
JPS5571734A (en) Composition
JPS5523187A (en) Photoohardening composition
JPS54158452A (en) Composition
JPS5592762A (en) Wax composition
JPS5580451A (en) Composition
JPS54139654A (en) Composition
JPS5523186A (en) Photoohardening composition
GB2020975B (en) Compositions containg cyanine compounds
JPS54152038A (en) Flameeproof*lowwsmoke hottmelt composition
JPS54107993A (en) Alphaacyanoacrylate composition
AU521319B2 (en) Filler composition
GB2015002B (en) Chemically modified asphalt compositions
JPS54147931A (en) Antiiulcer composition
HK80984A (en) Etomidate-containing compositions
NZ191048A (en) 1-benzoyl-3-pyridinyl-urea derivatives isecticidal compositions
GR64830B (en) Disinfectaut composition
PT69935A (en) Insecticidals compositions
ZA793302B (en) Fasciolicidal compositions
PT69225A (en) Compositions
SG8583G (en) Oil compositions
JPS54147934A (en) Antiiangina composition
PT70100A (en) Farmaceutical compositions
JPS5531878A (en) Lubricaing oil composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee